Ask AI
ProCE Banner Activity

子宫内膜癌分子学重新分类:确定适合接受免疫治疗的患者

Clinical Thought

阅读 Domenica Lorusso 博士有关子宫内膜癌管理的最新临床数据和免疫疗法现状的中文版评论。

This educational activity is intended for clinicians practicing medicine outside of the United States.

Released: March 26, 2021

Share

Supporters

Supported by an educational grant from

GlaxoSmithKline

Faculty Disclosure

Primary Author

Domenica Lorusso, MD, PhD, Prof

Head of Gynecological Oncology Medical Unit
Humanitas San Pio X
Full Professor of Obtetrics and Gynecology
Department of Biomedical Sciences, Humanitas University
Milan, Italy

医学博士和哲学博士 Domenica Lorusso 透露,她已从 Amgen、AstraZeneca、Clovis、GlaxoSmithKline、MSD 和 Pharmamar 收到咨询费;从 MSD 收到非 CME/CE 服务的费用;并从 AstraZeneca、Clovis、GlaxoSmithKline 和 Pharmamar 获得了其他财务或物资支持。